Catalyst Wire Dossier Catalyst Wire Dossier

Sodium Hyaluronate Ophthalmic Solution 0.18%

sodium hyaluronate ophthalmic solution 0.18% · Alcon Research LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Sodium Hyaluronate Ophthalmic Solution 0.18%, covering 2013-07-08 to 2013-07-08. Get the full timeline:

Most recent: Clinical Trial Update: Sodium Hyaluronate Ophthalmic Solution, 0.18% for Treatment of Dry Eye Syndrome [Phase 3]

See pricing